Bridging In Vitro Data to Clinical Outcomes with MetID
Profiling, characterising and identifying metabolites are key steps in drug discovery and development. Metabolite identification (MetID) studies show the presence of potential active or reactive metabolites and your molecule’s biotransformation.
SEKISUI XenoTech and Agilex Biolabs combine expertise in drug metabolism and mass spectrometry, pharmaceutical industry experience and advanced software to identify metabolites in in vivo and in vitro samples, helping accelerate drug development programs through first-in-human trials.
Key Learning Objectives
- Improving bioanalytical clinical outcomes with MetID characterisation
- How metabolite characterisation helps troubleshoot problems earlier in the drug program
- Test system selection for in vitro MetID
- Using MetID for tox species selection
- Integrating MetID with your bioanalytical program
- Why metabolite characterisation studies are not quantitative
- Regulatory expectations for MetID
Watch Now: Bridging In Vitro Data to Clinical Outcomes with MetID
This webinar is available on demand. Fill in the form to watch the full recording — we'll email you the link too.
- March 8, 2022
- kbiinfo@krishgen.com
- +91 22 49198700
Your details
Request the recording
Fill in your details and we'll email you the recording.
More Webinars
Shortcuts to Discovery and Characterization of Monoclonal Antibodies
Monoclonal antibody (mAb) discovery and characterization often face significant delays due to iterative screening cycles, late-stage functional failures, and downstream analytical bottlenecks. This webinar details five practical shortcuts that accelerate timelines from target validation to preclinical characterization.
View Webinar June 12, 2026Viral Vectors & CRISPR for Building Disease Models
Gene editing and viral vector technologies are transforming the development of advanced disease models for translational research.
View Webinar April 17, 2026Advanced Immunocompetent Primary Human Airway Models for Respiratory Disease Modeling
Advancements in human-relevant in vitro models are transforming how respiratory diseases are studied and how drug safety and efficacy are evaluated.
View Webinar